Searched for
ORAL SOLIDS AND INJECTABLES
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Eli Lilly Foundayo weight-loss pill vs Novo Nordisk Wegovy oral obesity treatment tablets: Which medicine is the most prescribed across U.S.?Eli Lilly Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on A...
- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
- Sai Parenteral's raises over Rs 122 crore from anchor investorsSai Parenteral's Ltd has raised over Rs 122 crore from anchor investors ahead of its IPO opening on March 24. The Hyderabad-based pharmaceu...
- USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unitAurobindo Pharma faces scrutiny. The US FDA inspected its Bachupally, Telangana plant. The inspection occurred between August 25 and Septem...
- Akums enters into Rs 1750 crore contract to supply pharma products to EuropeAkums Drugs & Pharmaceuticals has signed a long-term contract worth Rs 1760 crore with an unnamed global pharmaceutical company to manufact...
- Eli Lilly in advanced clinical trials for its weight-loss pillEli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess ...
- Optimising costs to beat price erosion in US market: Alembic PharmaceuticalsIn an interview to ET, Pranav Amin, Managing Director of Alembic Pharmaceuticals said the management still remains bullish on the US market...
- Aurobindo Pharma restructuring to unlock value for shareholders: Vishal Manchanda“Aurobindo injectable business can trade at up to 35x valuation. Aurobindo’s current trading multiple is around 10x. So there is a large up...
- Alembic Pharma raises Rs. 750 crore via QIPThe issue was subscribed at a price of Rs. 932 a share, lower than Thursday’s close at Rs. 1081.55 a share on Bombay Stock Exchange.
- Alembic Pharma gets board approval to raise up to Rs 1,000 crore via QIPThe board, at its meeting held on Monday, has accorded its approval to raise up to Rs 1,000 crore through a QIP issue of equity shares.
- Alembic Pharma jumps 3% as JV firm completes USFDA inspectionAlembic Pharma manufactures and markets generic pharmaceutical products across the globe.
- Alembic Pharma plans Rs 720-crore capex for FY19The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.
- Hold Aurobindo Pharma, target Rs 650: ICICI DirectHold Aurobindo Pharma Ltd. at a price target of Rs 650.0 .
- Cadila Healthcare extends losses; company clarifiesThe stock fell 2.97 per cent to hit a low of Rs 313.60 on BSE. This was the third day of consecutive fall for the stock.
- Glenmark to set up first manufacturing facility in USThe proposed facility would house three units to produce oral solids, injectables and topicals and begin production by the end of the curre...
Load More
